Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 1 10Phase 2 8Phase 3 6Phase 1/2 5Phase EARLY_PHASE1 1

Status

Completed 39Unknown 13Terminated 7Active not recruiting 6Recruiting 5Not yet recruiting 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 108Carcinoma, Non-Small-Cell Lung 95Prostatic Neoplasms 58Multiple Myeloma 45Neoplasms 38Neoplasm Metastasis 33Ovarian Neoplasms 26Melanoma 24Urinary Bladder Neoplasms 23Lung Neoplasms 22Colorectal Neoplasms 22Recurrence 21Leukemia, Lymphocytic, Chronic, B-Cell 21Parkinson Disease 4, Autosomal Dominant Lewy Body 20Carcinoma, Renal Cell 20Carcinoma, Hepatocellular 17Triple Negative Breast Neoplasms 16Nasopharyngeal Carcinoma 16Lymphoma, Non-Hodgkin 16Stomach Neoplasms 15Leukemia, Myeloid, Acute 15Lymphoma 14Squamous Cell Carcinoma of Head and Neck 13Small Cell Lung Carcinoma 13Fallopian Tube Neoplasms 12Colonic Neoplasms 12Carcinoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11

Interventions

durvalumab 4tremelimumab 2Bevacizumab 2lenvatinib 1Nivolumab 1Analgesia, Patient-Controlled 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Liver Neoplasms × Clear all
NCT05883644 2026-04-30

SIERRA

AstraZeneca

Phase 3 Active not recruiting
111 enrolled
Gastrointestinal

Liver Neoplasms

NCT03778957 2026-04-15

EMERALD-1

AstraZeneca

Phase 3 Active not recruiting
724 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05301842 2026-04-07

EMERALD-3

AstraZeneca

Phase 3 Active not recruiting
760 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03847428 2026-03-06

EMERALD-2

AstraZeneca

Phase 3 Active not recruiting
908 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03383458 2025-11-21

CheckMate 9DX

Bristol-Myers Squibb

Phase 3 Active not recruiting
545 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02523443 2025-07-22

Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
231 enrolled
Gastrointestinal

Agnosia, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡